Leveraging Success of COVID-19 Vaccine Development – Achieving Speed to Market Webinar

Extended Learning
Learning Level: Beginner/Intermediate
Time: 1100 – 1200 ET
Session Length: 1 hour

The pandemic was a unique time in our industry where there was a perfect storm of need, money, collaboration, and trial patients all available in abundance.  There was an atmosphere of all hands, and resources, on deck in the race to a COVID-19 vaccine.  That environment will be hard to achieve again but we can look back at the lessons learned and leverage the successes in the future.  One of the largest successes of the COVID-19 vaccine was the speed of which it was available to the public.  The average time to market for a new drug is over 10 years and the COVID-19 vaccine was available in less than a year.  This presentation will look at what made this success possible focusing on process development, facility design, and drug & product approval that could be leveraged in our industry going forward.

Learning Objective

This presentation will look at what made this success possible focusing on process development, facility design, and drug & product approval that could be leveraged in our industry going forward.

Speaker

Kristina Pumphrey, PE

Director of Process Engineering

Precis Engineering Inc

Register